Vivos Therapeutics, Inc.
VVOS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001716166
No open-market purchases or sales by Vivos Therapeutics, Inc. insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $242.7K in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Vivos Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- +3 vs. Q4 2022
- Shares held
- 5.01M
- +3.45M (+220.1%) vs. Q4 2022
- Total value
- $1.71M
- +$1.08M (+171.7%) vs. Q4 2022
- New holders
- 8
- 5 more added
- Sold out
- 5
- 4 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VVOS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 22 | $242.7K |
| Q1 2026 | 25 | $2.15M |
| Q4 2025 | 20 | $1.34M |
| Q3 2025 | 23 | $2.13M |
| Q2 2025 | 19 | $1.27M |
| Q1 2025 | 21 | $1.00M |
| Q4 2024 | 20 | $2.00M |
| Q3 2024 | 23 | $630.7K |
| Q2 2024 | 19 | $433.8K |
| Q1 2024 | 16 | $646.8K |
| Q4 2023 | 18 | $3.12M |
| Q3 2023 | 28 | $860.6K |
| Q2 2023 | 31 | $2.39M |
| Q1 2023 | 30 | $1.71M |
| Q4 2022 | 27 | $629.7K |
| Q3 2022 | 30 | $1.38M |
| Q2 2022 | 28 | $2.82M |
| Q1 2022 | 28 | $6.66M |
| Q4 2021 | 29 | $5.02M |
| Q3 2021 | 37 | $9.14M |
| Q2 2021 | 29 | $11.7M |
| Q1 2021 | 18 | $5.45M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Vivos Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Strategic Wealth Designers | 3,219,705 | $1.10M | 0.20% | +3,219,705 | New |
| Vanguard Group Inc | 719,167 | $245.3K | 0.00% | −12,675−1.7% | Reduced |
| Geode Capital Management, LLC | 201,941 | $68.9K | 0.00% | 00.0% | Unchanged |
| Bard Associates Inc | 201,704 | $68.8K | 0.03% | 00.0% | Unchanged |
| Godsey & Gibb Associates | 92,999 | $31.7K | 0.00% | +92,999 | New |
| Two Sigma Investments, LP | 91,013 | $31.0K | 0.00% | +91,013 | New |
| Renaissance Technologies LLC | 88,900 | $30.0K | 0.00% | +72,900+455.6% | Added |
| Credit Agricole S A | 59,103 | $20.2K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 48,649 | $16.6K | 0.00% | +1,542+3.3% | Added |
| Virtu Financial LLC | 46,013 | $16.0K | 0.00% | +46,013 | New |
| State Street Corp | 45,650 | $15.6K | 0.00% | 00.0% | Unchanged |
| Apexium Financial, LP | 40,667 | $13.9K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 33,204 | $11.0K | 0.00% | +16,278+96.2% | Added |
| Northern Trust Corp | 29,655 | $10.1K | 0.00% | 00.0% | Unchanged |
| Perkins Capital Management Inc | 22,500 | $8.00K | 0.01% | −29,500−56.7% | Reduced |
| Millennium Management LLC | 19,118 | $7.00K | 0.00% | +19,118 | New |
| Wealth Alliance Advisory Group, LLC | 17,498 | $5.97K | 0.00% | −8,751−33.3% | Reduced |
| Lincoln National Corp | 14,817 | $5.05K | 0.00% | 00.0% | Unchanged |
| Ronald Blue Trust, Inc. | 4,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 6,100 | $2.00K | 0.00% | +6,100 | New |
| FMR LLC | 3,600 | $1.23K | 0.00% | +3,600 | New |
| Stephens Consulting, LLC | 1,500 | $512 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1,400 | $478 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 1,308 | $446 | 0.00% | −2,292−63.7% | Reduced |
| Kozak & Associates, Inc. | 1,205 | $411 | 0.00% | 00.0% | Unchanged |
| Global Retirement Partners, LLC | 570 | $182 | 0.00% | 00.0% | Unchanged |
| Toth Financial Advisory Corp | 200 | $69 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 128 | $44 | 0.00% | +12+10.3% | Added |
| Royal Bank of Canada | 332 | $0 | 0.00% | +232+232.0% | Added |
| Simplex Trading, LLC | 548 | $0 | 0.00% | +548 | New |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −35,209−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −18,812−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −12,213−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −3,500−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −46−100.0% | Sold out |